Active Ingredient: TOVORAFENIB
Proprietary Name: OJEMDA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217700
Product Number: 001
Approval Date: Apr 23, 2024
Applicant Holder Full Name: DAY ONE BIOPHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information